Here, we leveraged whole-exome sequencing (WES) data from 454,775 participants of the population-based UK Biobank (UKB) study to explore whether rare damaging variants in the CCR2 gene are associated with cardiovascular disease risk, burden of atherosclerosis, and traditional vascular risk biomarkers. Here, CCR2 is linked to cardiovascular disorder.